CAS NO: | 1481677-78-4 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | UNC0642 is a potent and selective lysine methyltransferasesG9aandGLPinhibitor, with anIC50of<2.5 nM forG9a. | ||||||||||||||||
IC50& Target | IC50:<2.5 nM (G9a)[1] | ||||||||||||||||
体外研究 (In Vitro) | UNC0642 displays highin vitroand cellular potency, low cell toxicity, and excellent selectivity. UNC0642 is competitive with the peptide substrate and non-competitive with the cofactor SAM. The Kiof UNC0642 is determined to be 3.7±1 nM. UNC0642 displays highin vitropotency for GLP (IC50< 2.5 nM), similar to G9a. UNC0642 is more than 300-fold selective for G9a and GLP over a broad range of kinases, GPCRs, transporters, and ion channels. UNC0642 exhibits high potency at reducing the H3K9me2 mark, low cell toxicity, and good separation of functional potency and cell toxicity in a number of cell lines. It reduces clonogenicity in PANC-1 cells, a pancreatic carcinoma cell line[1]. | ||||||||||||||||
体内研究 (In Vivo) | A single intraperitoneal (IP) injection (5 mg/kg) of UNC0642 results in a plasma Cmax(maximum concentration) of 947 ng/mL and an AUC (area under the curve) of 1265 hr*ng/mL[1]. | ||||||||||||||||
分子量 | 546.70 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C29H44F2N6O2 | ||||||||||||||||
CAS 号 | 1481677-78-4 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 50 mg/mL(91.46 mM;Need ultrasonic) H2O :< 0.1 mg/mL (ultrasonic;warming;heat to 60℃)(insoluble) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|